Axogen, Inc. Common Stock vs. Electromed, Inc.
Axogen, Inc. Common Stock and Electromed, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AXGN | ELMD | |
|---|---|---|
| Market Cap | $2.55 billion | $233.25 million |
| Revenue (TTM) | — | $73.78 million |
| Net Income (TTM) | — | $11.30 million |
AXGN leads on 1 of 1 size & scale factors.
Valuation
| AXGN | ELMD | |
|---|---|---|
| P/E Ratio | — | 21.45 |
| Price / Book | — | 4.32 |
| Price / Sales | — | 3.16 |
AXGN and ELMD split the valuation factors evenly.
Profitability
| AXGN | ELMD | |
|---|---|---|
| Net Margin | — | 15.32% |
| Return on Equity | — | 20.94% |
AXGN and ELMD split the profitability factors evenly.
Risk & Sentiment
| AXGN | ELMD | |
|---|---|---|
| Short Interest | 2.05% | 0.81% |
ELMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: AXGN overview, AXGN financials, ELMD overview, ELMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
